AF
CATX icon

Advisornet Financial’s Perspective Therapeutics CATX Stock Holding History

Advisornet Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,456
Closed -$17K – 2013
2021
Q4 		$17K Buy
4,456
+201
+5% +$1.07K ﹤0.01% 1326
2021
Q3 		$27K Hold
4,255
– – ﹤0.01% 1166
2021
Q2 		$34K Buy
4,255
+1,182
+38% +$10.4K ﹤0.01% 1096
2021
Q1 		$34K Buy
3,073
+685
+29% +$10.3K ﹤0.01% 1046
2020
Q4 		$11K Hold
2,388
– – ﹤0.01% 1259
2020
Q3 		$14K Hold
2,388
– – ﹤0.01% 1183
2020
Q2 		$13K Hold
2,388
– – ﹤0.01% 1220
2020
Q1 		$13K Buy
+2,388
New +$18K ﹤0.01% 1190

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Advisornet Financial's CATX Position: Q1 2022 in Review

Advisornet Financial sold out of Perspective Therapeutics (CATX) in Q1 2022, closing a stake of 4,456 shares — an estimated $17K sold.

Advisornet Financial first reported a position in CATX in Q1 2020 and held it in 8 quarters. The position peaked at $34K in Q2 2021. 39 funds tracked by Wall St. Rank hold CATX as of Q1 2022.

  • Advisornet Financial reported no remaining Perspective Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Advisornet Financial sold 4,456 Perspective Therapeutics shares in Q1 2022, an estimated $17K.
  • Advisornet Financial first reported a position in Perspective Therapeutics in Q1 2020 and held it in 8 quarters.
  • Advisornet Financial's Perspective Therapeutics position peaked at $34K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2022.

Based on Advisornet Financial's 13F filing for Q1 2022, filed 14 Apr 2022.